Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 8/20 | 0.51 |
| ▸ | ACE | P12821 | 8/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | CPA1 | P15085 | 2/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2990815 | 0.93 | POLB (0.55) | MMEACEPOLBCPA1ACE2 | |
| SCHEMBL2976458 | 0.86 | FOLH1 (0.51) | FOLH1MMEACECPA1ACE2 | |
| SCHEMBL2982721 | 0.86 | FOLH1 (0.51) | FOLH1MMEACECPA1ACE2 | |
| SCHEMBL2984585 | 0.85 | ACE (0.47) | FOLH1MMEACECPA1ACE2 | |
| SCHEMBL2980632 | 0.85 | NOS2 (0.47) | FOLH1MMEACECPA1ACE2 | |
| SCHEMBL2982925 | 0.85 | FOLH1 (0.52) | FOLH1MMEACEMMP9MMP8 | |
| SCHEMBL16017459 | 0.85 | MMP9 (0.60) | FOLH1MMEACEMMP9MMP8 | |
| SCHEMBL2979320 | 0.84 | NOS2 (0.46) | FOLH1MMEACECPA1ACE2 | |
| SCHEMBL2985294 | 0.81 | POLB (0.50) | MMEPOLBTSHR | |
| SCHEMBL2982927 | 0.80 | POLB (0.49) | MMEACEPOLBTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | claimed |
| US-7777073-B2 | Topical delivery system for antiaging and skin whitening agents | BIODERM RESEARCH (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | FOLH1 2609/4885MME 1263/4885ACE 208/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.